High resolution magnetic resonance imaging of retinoblastoma
Main Article Content
Abstract
Purpose: To describe the imaging characterization of high-resolution magnetic resonance imaging of retinoblastoma
Material and method: About 50 patients were diagnosed and monitored for retinoblastoma treatment at the National Eye Hospital and performed 3T magnetic resonance at Saint Paul General Hospital from October 2020 to May 2022. Description of tumor intraocular lesion: Number, location of tumor, largest diameter. Description of tumor characteristics: Signals on sequences T1W, T2W, FLAIR, DWI and enhancement properties after injection. Other accompanying features: Intra-tumor calcification, retinal detachment, vitreous hemorrhage, optic nerve invasion, invasion outside the eyeball, intracranial lesions
Results: 50 patients in the study had an average age of 21.2 months, and the age of the one-eye disease group was higher than that of the two-eyed disease group. 3T MRI is a good method for diagnosing retinoblastoma tumors, with the largest dimension measuring 13.8 ± 4.2 mm, the tumor distribution is mainly on the retina in the post-equatorial region. Tumor image on MRI compared with vitreous signal, mostly increased signal on T1W (92.6%), decreased on T2W (98.8%), increased on FLAIR (100%), restriction on DWI (100%) and enhancement after injection. Signs of calcification are specific for retinoblastoma, however, on MRI the ability to detect calcification is limited. Although the detection of calcification is limited, it has good ability in invasive assessment such as choroidal invasion (15.6%), scleral invasion (3.1%), optic nerve invasion (31.3). %). Severe prognostic signs such as retinal detachment (34.4%), vitreous bleeding (26.6%).
Conclusion: 3T magnetic resonance is a good method of diagnosing retinoblastomas as well as assessing the invasiveness of tumors.
Article Details
Keywords
Retinoblastoma, High resolution magnetic resonance imaging of retinoblastoma
References
2. Shifa JZ, Gezmu AM. Presenting signs of retinoblastoma at a tertiary level teaching hospital in Ethiopia. Pan Afr Med J. 2017;28.
3. Zomor HE, Nour R, Alieldin A, et al. Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. J Egypt Natl Cancer Inst. 2015;27(4):195-203.
4. Chung SE, Sa HS, Koo HH, Yoo KH, Sung KW, Ham DI. Clinical manifestations and treatment of retinoblastoma in Korea. Br J Ophthalmol. 2008;92(9):1180-1184.
5. Nguyễn Xuân Tịnh (1993). Góp phần nhận định bệnh ung thư võng mạc hiện nay. Luận văn bác sĩ nội trú.
6. Gupta R, Vemuganti GK, Reddy VAP, Honavar SG. Histopathologic Risk Factors in Retinoblastoma in India. Arch Pathol Lab Med. 2009;133(8):1210-1214.
7. Đỗ Như Hơn (2012). Mắt trẻ em. Nhãn khoa, Vol. 2. Nhà xuất bản y học, 436 – 611.
8. Lemke AJ, Kazi I, Mergner U, et al. Retinoblastoma—MR appearance using a surface coil in comparison with histopathological results. Eur Radiol. 2007;17(1):49-60.
9. Kucharczyk W, Henkelman RM. Visibility of calcium on MR and CT: can MR show calcium that CT cannot? AJNR Am J Neuroradiol. 1994;15(6):1145-1148.